Ritholtz Wealth Management Eli Lilly & CO Transaction History

Ritholtz Wealth Management

$2.87 Billion
Q1 2024

A detailed history of Ritholtz Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Ritholtz Wealth Management holds 23,284 shares of LLY stock, worth $21.3 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

23,284

Previous 23,082 0.88%

Holding current value

$21.3 Million

Previous $13.5 Million 34.64%

% of portfolio

0.63%

Previous 0.53%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $119,624 - $160,040	202 Added 0.88%	23,284 $18.1 Million
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $821,397 - $968,319	-1,564 Reduced 6.35%	23,082 $13.5 Million
Q3 2023 Oct 13, 2023	BUY	$434.7 - $599.3 $133,018 - $183,385	306 Added 1.26%	24,646 $13.2 Million
Q2 2023 Jul 14, 2023	BUY	$350.74 - $468.98 $231,839 - $309,995	661 Added 2.79%	24,340 $11.4 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $381,453 - $447,998	-1,228 Reduced 4.93%	23,679 $8.13 Million

Q4 2022 Jan 18, 2023	SELL	$321.55 - $374.67 $573,323 - $668,036	-1,783 Reduced 6.68%	24,907 $0
Q3 2022 Oct 18, 2022	BUY	$296.48 - $337.87 $5.06 Million - $5.77 Million	17,064 Added 177.27%	26,690 $8.63 Million
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $518,437 - $608,722	1,860 Added 23.95%	9,626 $3.12 Million
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $633,193 - $786,898	2,698 Added 53.24%	7,766 $2.22 Million
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $226,873 - $281,551	1,009 Added 24.86%	5,068 $1.4 Million
Q3 2021 Oct 14, 2021	BUY	$221.6 - $272.71 $62,934 - $77,449	284 Added 7.52%	4,059 $938,000
Q2 2021 Jul 20, 2021	BUY	$180.55 - $233.54 $140,106 - $181,227	776 Added 25.88%	3,775 $866,000
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $85,446 - $110,614	-520 Reduced 14.78%	2,999 $560,000
Q4 2020 Jan 19, 2021	BUY	$130.46 - $172.63 $12,132 - $16,054	93 Added 2.71%	3,519 $594,000
Q3 2020 Oct 23, 2020	SELL	$146.22 - $169.13 $13,744 - $15,898	-94 Reduced 2.67%	3,426 $507,000
Q2 2020 Jul 15, 2020	BUY	$136.42 - $164.18 $177,482 - $213,598	1,301 Added 58.63%	3,520 $578,000
Q1 2020 Apr 09, 2020	BUY	$119.05 - $147.35 $264,171 - $326,969	2,219 New	2,219 $308,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Account

Ritholtz Wealth Management Eli Lilly & CO Transaction History